ArticleFrontiers in medicine2025
Heterotaxy polysplenia syndrome with cholangiopancreatic cancer: a case report and literature review.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heterotaxy polysplenia syndrome is a rare condition characterized by multiple abnormal spleens and irregular placement of various organs. Some patients have been documented as developing various types of cancers, although the association with heterotaxy polysplenia syndrome remains uncertain. Most cases of heterotaxy polysplenia syndrome are isolated anomalies, but there are rare instances where it appears in closely related individuals, suggesting possible genetic inheritance. Case presentation: We report the case of a 36-year-old woman with heterotaxy polysplenia syndrome, who presented with choledocholithiasis, thickening and stenosis of the hepatic portal bile duct wall, duodenal atresia, and congenital pancreatic insufficiency. Following recovery from a COVID-19 infection, the patient incidentally identified a mass in the upper abdomen. Pathological examination revealed the mass to be a poorly differentiated adenocarcinoma of pancreaticobiliary origin. Additionally, a familial pattern of situs inversus and breast cancer was observed. In this report, we also provide a comprehensive literature review to enhance the understanding of heterotaxy polysplenia syndrome and to explore the potential association between this condition and tumor development. Conclusion: Our report contributes to the current knowledge about heterotaxy polysplenia syndrome and its potential association with tumors. Effective integration of clinical diagnostic information, exploration of precise means of diagnosing and treating rare diseases, and incorporation of the patient's familial background are promising for future research and clinical interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.